Clinical Trials in Minneapolis

Showing 11081-11100 of 12,418 trials

3-AP and Gemcitabine in Treating Patients With Unresectable or Metastatic Pancreatic Cancer

NCT00064051

RATIONALE: Drugs used in chemotherapy such as gemcitabine use different ways to stop tumor cells from dividing so they stop growing or die. 3-AP may stop the growth of tumor cells by blocking the enzymes necessary for tumor cell growth and may help gemcitabine kill more cancer cells by making them more sensitive to the drug. PURPOSE: This phase II trial is studying how well giving gemcitabine together with 3-AP works in treating patients with unresectable or metastatic pancreatic cancer.

Pancreatic Cancer

Vion PharmaceuticalsStarted Jan 2003

Chicago, Illinois, United States • Indianapolis, Indiana, United States • Minneapolis, Minnesota, United States +4 more locations

COMPLETED< 1 mile

Urinary Biomarkers of the Progression of Alport Kidney Disease

NCT01705132

The purpose of the study is to determine if there are certain laboratory tests that can be performed to detect substances or features in a child's urine that can be used to measure the progress of Alport kidney disease and the effects of treatment. These tests and their results could be of use to measure responses to new treatments in future clinical trials.

Alport Syndrome

University of Minnesota80 participantsStarted Jun 2012

Minneapolis, Minnesota, United States

TERMINATEDPhase 4< 1 mile

Rapid Assessment of Bedside BNP In Treatment of Heart Failure (RABBIT)

NCT00206856

To determine the clinical utility of using the Triage® BNP Test to guide therapy in outpatients with heart failure

Heart Failure

Abbott RDx Cardiometabolic720 participantsStarted Jul 2003

Scottsdale, Arizona, United States • San Diego, California, United States • San Francisco, California, United States +26 more locations

3-AP and Gemcitabine in Treating Patients With Unresectable or Metastatic Pancreatic Cancer

Urinary Biomarkers of the Progression of Alport Kidney Disease

Rapid Assessment of Bedside BNP In Treatment of Heart Failure (RABBIT)

Find Trials by Condition in Minneapolis

Comparison of Aneuploidy Risk Evaluations

Vascular Effects of Rosiglitazone Versus Glyburide in Type 2 Diabetic Patients

Balloon REmodeling Antrostomy THErapy Study

Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus

Efficacy and Safety of Adalimumab and Methotrexate (MTX) Versus MTX Monotherapy in Subjects With Early Rheumatoid Arthritis

A Study In Patients With Neuropathic Pain From Diabetic Peripheral Neuropathy (DPN)

Armodafinil (CEP-10953) for Treatment of Narcolepsy, Obstructive Sleep Apnea/Hypopnea Syndrome, or Chronic Shift Work Sleep Disorder

Open Label Extension Study of STX209 (Arbaclofen) in Autism Spectrum Disorders

An Open Label Extension Study in Subjects With Fragile X Syndrome

A Clinical Study in Subjects With Neuropathic Pain From PHN Who Have Had an Inadequate Response to Gabapentin Treatment

Randomized Study of Sorafenib Dose Escalation in Patients With Previously Untreated Metastatic Renal Cell Carcinoma

A Study to Evaluate Bleeding Patterns With Three Different Doses of DR-1031 Compared to Seasonale

Case-Control Viramune (Nevirapine) Toxicogenomics Study

A Study to Evaluate High Protein Supplementation in HIV-Positive Patients With Stable Weight Loss

A Study of Combination Therapy With PEGASYS (Pegylated Interferon Alfa-2a (40KD)) and Copegus (Ribavirin) in Patients With Chronic Hepatitis C Genotype 2 or 3 Who Do Not Achieve a Rapid Viral Response

Prevention Trial of Family Focused Treatment in Youth at Risk for Psychosis

VNP40101M in Treating Patients With Acute Myelogenous Leukemia or High-Risk Myelodysplasia